Loading data
GLSINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 17.22 m USD | 15.48 m USD | 7.7 m USD | 6.48 m USD | 3.56 m USD |
| Operating profit | -19.45 m USD | -17.64 m USD | -9.33 m USD | -8.04 m USD | -4.6 m USD |
| Net income (reported basis) | -19.36 m USD | -17.41 m USD | -8.89 m USD | -7.83 m USD | -4.57 m USD |
| Basic earnings per share | -1.43 USD/share | -1.34 USD/share | -0.69 USD/share | -0.61 USD/share | -0.35 USD/share |
| Diluted earnings per share | -1.43 USD/share | -1.34 USD/share | -0.69 USD/share | -0.61 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.